LUMZZI

Serial Number 88352146
606

Registration Progress

Application Filed
Mar 22, 2019
Under Examination
Sep 3, 2019
Approved for Publication
Jul 9, 2019
Published for Opposition
Jul 9, 2019
Registered

Basic Information

Serial Number
88352146
Filing Date
March 22, 2019
Published for Opposition
July 9, 2019
Abandonment Date
October 10, 2022
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Oct 10, 2022
Classes
005

Rights Holder

Alnylam Pharmaceuticals, Inc.

03
Address
300 Third Street
Cambridge, MA 02142

Ownership History

Alnylam Pharmaceuticals, Inc.

Original Applicant
03
Cambridge, MA

Alnylam Pharmaceuticals, Inc.

Owner at Publication
03
Cambridge, MA

Legal Representation

Attorney
Sarah Anne Keefe

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

38 events
Date Code Type Description
Oct 11, 2022 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Oct 10, 2022 ABN6 S ABANDONMENT - NO USE STATEMENT FILED
Jul 27, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 27, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 27, 2022 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jul 27, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 3, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 2, 2022 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Feb 2, 2022 EX5G S SOU EXTENSION 5 GRANTED
Jan 24, 2022 EEXT I SOU TEAS EXTENSION RECEIVED
Jan 24, 2022 EXT5 S SOU EXTENSION 5 FILED
Aug 10, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 6, 2021 EEXT I SOU TEAS EXTENSION RECEIVED
Aug 6, 2021 EXT4 S SOU EXTENSION 4 FILED
Aug 6, 2021 EX4G S SOU EXTENSION 4 GRANTED
Feb 27, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 25, 2021 EEXT I SOU TEAS EXTENSION RECEIVED
Feb 25, 2021 EXT3 S SOU EXTENSION 3 FILED
Feb 25, 2021 EX3G S SOU EXTENSION 3 GRANTED
Sep 4, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 2, 2020 EEXT I SOU TEAS EXTENSION RECEIVED
Sep 2, 2020 EXT2 S SOU EXTENSION 2 FILED
Sep 2, 2020 EX2G S SOU EXTENSION 2 GRANTED
Jun 14, 2020 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 14, 2020 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 14, 2020 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 5, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 3, 2020 EEXT I SOU TEAS EXTENSION RECEIVED
Mar 3, 2020 EXT1 S SOU EXTENSION 1 FILED
Mar 3, 2020 EX1G S SOU EXTENSION 1 GRANTED
Sep 3, 2019 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 9, 2019 PUBO A PUBLISHED FOR OPPOSITION
Jul 9, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 19, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 4, 2019 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 3, 2019 DOCK D ASSIGNED TO EXAMINER
Apr 9, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 26, 2019 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of primary hyperoxaluria
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Translation
The wording "LUMZZI" has no meaning in a foreign language.

Classification

International Classes
005